The question isn’t whether we should slow down AI development. It’s whether we still can

There is no more serious issue for humanity than the breakneck pace of the progress of AI, and the seemingly diminishing ...

The problem where every shared article shows the 'top page image'. How I solved it in 180 lines without a major site overhaul

Series: 'Digital Craft Co-development Journal with an AI Agent Team' Part 9 [OGP Delivery Edition] The URL is different for ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX)

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...